Tag: Glenmark Pharmaceuticals

Glenmark Pharmaceuticals secures FDA approval for generic version of Otezla Tablets

businessnewstoday- October 17, 2023

Glenmark Pharmaceuticals Ltd. has successfully secured the final approval from the United States Food & Drug Administration (U.S. FDA) for its Apremilast Tablets in 10 ... Read More

Ichnos Sciences strikes exclusive global deal with Astria Therapeutics for OX40 antibody portfolio

businessnewstoday- October 12, 2023

Ichnos Sciences, a prominent clinical-stage biotechnology firm specializing in pioneering multispecific antibodies for oncology and under the ownership of Glenmark Pharmaceuticals, has announced a momentous ... Read More

Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma Limited

businessnewstoday- September 21, 2023

Glenmark Pharmaceuticals (Glenmark Pharma), a research-led global pharmaceutical player, has inked a deal with Nirma Limited to divest a substantial 75% stake in its offshoot, ... Read More

Glenmark Pharmaceuticals gets FDA approval for generic Protopic Ointment

businessnewstoday- August 17, 2023

Glenmark Pharmaceuticals Ltd., a global leader in pharmaceutical research, has secured the final nod from the U.S. Food & Drug Administration (U.S. FDA) for its ... Read More

Glenmark Pharmaceuticals gets FDA final approval for Compazine generic

businessnewstoday- March 20, 2023

Glenmark Pharmaceuticals has bagged final approval for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg from the US Food & Drug Administration (FDA). The ... Read More

Glenmark Pharmaceuticals set to begin clinical trial of GRC 54276 in US

businessnewstoday- March 17, 2023

Glenmark Pharmaceuticals, through its subsidiary Glenmark Specialty, is set to begin a first-in-human, phase 1/2 clinical study of GRC 54276 in the US for the ... Read More

Glenmark Pharmaceuticals gets FDA second tentative approval for Saxagliptin Tablets

businessnewstoday- February 17, 2023

Glenmark Pharmaceuticals Inc., USA has secured a second tentative approval from the United States Food and Drug Administration (FDA) for Saxagliptin Tablets, 2.5 mg and ... Read More

Glenmark Pharmaceuticals to sell certain dermatology brands to Eris Lifesciences

businessnewstoday- January 18, 2023

Glenmark Pharmaceuticals has agreed to sell certain brands from its dermatology segment in India and Nepal to Eris Oaknet Healthcare, a fully-owned subsidiary of Eris ... Read More

Glenmark Pharmaceuticals rolls out heart failure treatment Sacu V in India

businessnewstoday- January 17, 2023

Glenmark Pharmaceuticals said that it has rolled out the sacubitril + valsartan tablets for the treatment of heart failure in India under the brand name ... Read More

Glenmark Pharmaceuticals launches Bumex Injection generic in US

businessnewstoday- January 10, 2023

Glenmark Pharmaceuticals said that its US-based subsidiary has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) SingleDose Vials and 2.5 mg/10 mL (0.25 mg/mL) ... Read More